$INSM
Insmed, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Flagged at $119.97 at 09:35 AM on Nov 19, then ran to $149.07 +24% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Insmed, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Flagged at $119.97 at 09:35 AM on Nov 19, then ran to $149.07 +24% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is INSM down today? It is at $143.15, -0.91% on the day and -0.91% pre-market, and our scanner flagged it 166 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment INSM spikes, and full due diligence on INSM — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $INSM 166 times in the last 30 days. Create a free account to track $INSM, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on INSM from our scanner (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on INSM today.
Likely catalystInsmed Reports Third-Quarter 2026 Financial Results and Provides Business UpdateReported —Total Company Revenues of $524.4 Million for the Third Quarter of 2026—Reported Revenues of $400.1 Million for the Third Quarter of 2026, Reflecting 29% Growth Over the Second Quarter of 2026—Reported —ARIKAYCE® (amikacin liposome inhalation suspension) Revenues of $124.4 Million for the Third Quarter of 2026, Reflecting 9% Growth Over the Third Quarter of 2025—, from an SEC filing. Read it →Latest filing144Notice of proposed insider sale (144)Nov 19, 2026 · todaySources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
From SEC 13F quarterly holdings (position as of quarter-end, not a transaction date or price) and dated 13D/13G stake filings. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Hudson Paul Director | Acquired (grant/award) | +6K | n/a | 6K | n/a | Oct 19, 26 |
Koppikar Utpal Director | Acquired (grant/award) | +6K | n/a | 6K | n/a | Oct 19, 26 |
Brennan David R Director | Sold (automatic/other) | -25K 0.01% of company | sold 39% | 39K | $3.1M at $124.00 | Sep 9, 26 |
Sharoky Melvin Md Director | Sold (automatic/other) | -5K | sold 19% | 22K | $638K at $127.53 | Aug 17, 26 |
Adsett Roger Officer | Sold (automatic/other) | -240K 0.1% of company | sold 71% | 99K | $32.0M at $133.27 | Aug 10, 26 |
Adsett Roger Officer | Other | 240K 0.1% of company | added 100% | 339K | $3.3M at $13.67 | Aug 10, 26 |
Flammer Martina M.D. Officer | Sold (automatic/other) | -27K 0.01% of company | sold 31% | 60K | $3.5M at $127.00 | Aug 6, 26 |
Flammer Martina M.D. Officer | Other | 27K 0.01% of company | added 45% | 88K | $515K at $18.95 | Aug 6, 26 |
Lewis William Officer | Sold (automatic/other) | -11K | sold 4.0% | 259K | $1.1M at $105.62 | Jul 23, 26 |
Lewis William Officer | Other | 11K | added 4.1% | 270K | $184K at $17.16 | Jul 23, 26 |
Lewis William Officer | Sold (automatic/other) | -11K | sold 4.0% | 259K | $1.2M at $116.55 | Jul 9, 26 |
Lewis William Officer | Other | 11K | added 4.1% | 270K | $184K at $17.16 | Jul 9, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.






The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on INSM from our scanner (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on INSM today.
INSM last traded at $143.15, down 0.91% on the day and down 0.91% pre-market. The price and chart above update live during market hours (4 AM to 8 PM ET).
The INSM Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged INSM 166 times in the last 30 days.
INSM (Insmed, Inc.) trades on XNAS, with a market cap of about $31.69B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge INSM for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
Halt WatchTop 5 most halted stocks todayWatch on YouTube · Nov 19
$INSM discussion
Sign in to ask a question or join the discussion.